Moreover, ANO1 has been investigated in additional cancers, including head and neck squamous cell carcinoma (HNSCC), where its amplification and elevated expression were associated with poor survival outcomes, indicating its potential as a prognostic marker and therapeutic target [11]. Here, ANO1 is linked to cancer.